People: Valeant Pharmaceuticals International Inc (VRX)

VRX on New York Consolidated

146.06USD
19 Dec 2014
Price Change (% chg)

$3.06 (+2.14%)
Prev Close
$143.00
Open
$143.76
Day's High
$146.60
Day's Low
$142.56
Volume
2,044,308
Avg. Vol
2,619,295
52-wk High
$153.10
52-wk Low
$106.00

Search Stocks

Melas-Kyriazi, Theo 

Brief Biography

Mr. Theo Melas-Kyriazi is Independent Director of Valeant Pharmaceuticals International Inc., since September 2010. He has been the Chief Financial Officer of Levitronix Technologies LLC, magnetically levitated bearingless motor technology, since 2011, and served as the Chief Financial Officer of its affiliate, Levitronix LLC since 2006. He was the Chief Financial Officer of Thermo Electron Corporation from January 1999 through October 2004. Mr. Melas-Kyriazi was a Vice President of Thermo Electron Corporation during 1998, in charge of corporate strategy; he served as the CEO of Thermo Spectra Corporation, a publicly-traded majority-owned subsidiary of Thermo Electron, from 1994 to 1998, and was Treasurer of Thermo Electron Corporation and all of its publicly traded subsidiaries from 1988 to 1994. Mr. Melas-Kyriazi is a former director of VPI, Helicos BioSciences Corporation, Cyberkinetics Neurotechnology Systems, Inc. and Glenrose Instruments Inc.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

J. Michael Pearson

6,112,980

Bhaskar Chaudhuri

3,626,560

Howard Schiller

6,715,710

Peter Blott

937,182

Elisa Karlson

1,607,820

Robert Chai-Onn

1,775,040
As Of 30 Dec 2012
Search Stocks